Advertisement

Use of Propafenone for the Prevention of Ventricular Hyperkinetic Arrhythmias in the Mitral Valve Prolapse Syndrome

  • F. Furlanello
  • G. B. Durante
  • P. Dal Forno
  • L. Frisanco
  • G. Mosna
  • R. Bettini
  • M. Disertori
  • G. Vergara
  • A. Del Favero
  • E. Stirpe
Conference paper

Abstract

Sudden death has been reported to occurr in 1,4% of patients suffering from mitral valve prolapse (MVP). Ventricular hyperkinetic arrhythmias (VHA), also potentially malignant, are found in a substantial number of patients suffering from this syndrome. Thus effective antiarrhythmic treatment is necessary.

Keywords

Antiarrhythmic Agent Mitral Valve Prolapse Graphic Criterion Ventricular Ectopic Beat Ventricular Tachy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Disertori M, Vergara G, Dal Forno P, Inama G, Furlanello F (1981) Le Nuove Frontière délie Aritmie Piccin p. 213Google Scholar
  2. Swartz MH et al. (1977) Am J Med 62: 377PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • F. Furlanello
  • G. B. Durante
  • P. Dal Forno
  • L. Frisanco
  • G. Mosna
  • R. Bettini
  • M. Disertori
  • G. Vergara
  • A. Del Favero
  • E. Stirpe

There are no affiliations available

Personalised recommendations